Senior insider sale
Chief Financial Officer at LIFECORE BIOMEDICAL, INC. \DE\ — senior position signals high conviction
$156.4K
30.62K shares
What this filing means
MORBERG JOHN D plans to sell 30.62K shares of LIFECORE BIOMEDICAL, INC. \DE\ valued at approximately $156.4K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 10/7/2024ACC: 0001957799-24-000262
Officer· Chief Financial Officer
Since Jan 2021
30.62K
Shares to sell
$156.4K
Approx. market value
12.62K
Acquired (3 months)
1
Planned
3 completed
Securities Acquired — Last 3 Months1
Open Market Purchase
N/A
2/5/2021
12.62KTotal acquired12.62K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
2/5/2021 | Open Market Purchase N/A | 12.62K | — |
| Total | 12.62K | ||
Planned & Completed Dispositions4
Completed
—Completed
Units to sell
12K
Market value
$60.7K
10/4/2024
—Completed
Units to sell
3K
Market value
$14.7K
10/2/2024
—Completed
Units to sell
3K
Market value
$15.5K
9/20/2024
Planned — Approximate Date
NasdaqPlanned
Units to sell
12.62K
Market value
$65.5K
10/7/2024
Total
Units
30.62K
Value
$156.4K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
10/4/2024 | 12K | $60.7K | — | Completed |
10/2/2024 | 3K | $14.7K | — | Completed |
9/20/2024 | 3K | $15.5K | — | Completed |
| Planned — Approximate Date | ||||
10/7/2024 | 12.62K | $65.5K | Nasdaq | Planned |
| Total | 30.62K | $156.4K | ||